ONESOURCE — Onesource Specialty Pharma Share News
0.000.00%
Last trade - 00:00- IN₹178.39bn
- IN₹192.23bn
- IN₹14.22bn
Brief: Onesource Specialty Pharma March-Quarter Consol Profit 46 Million Rupees
Brief: Onesource Specialty Pharma Says Orbicular Secures Tentative U.S. FDA ANDA Approval For Generic Ozempic
Brief: Onesource Specialty Pharma Says EU-GMP Certification For Unit II Manufacturing Facility Renewed
Brief: Onesource Specialty Says Onesource-Hikma Secures Approval To Commercialise Generic Ozempic In Saudi Arabia
Brief: Onesource Specialty Pharma Posts Dec-Quarter Consol Loss Of 887 Million Rupees
India's OneSource eyes weight-loss drug boost to order book
Brief: Onesource Specialty Pharma Proposes To Subscribe To Shares Of Xbrane Biopharma AB
Brief: Onesource Specialty Pharma Approves Consolidation Of Singapore Business Ops
Brief: Onesource Specialty Pharma Says Unit 2 Granted GMP Certification By Anvisa
Brief: Onesource Specialty Pharma Gets Tax Adjustment Order Of 425.95 Million Rupees
Brief: Onesource Specialty Pharma Dec-Quarter Consol Loss 688.5 Mln Rupees